X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 29/Jan 16:01

Mindfulness-Based Groups Tied to Significant Reduction in Opioid Craving

WEDNESDAY, Jan. 29, 2025 -- For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support group for opioid use, substance use, and reductions in anxiety, but demonstrates a larger...

Articles similaires

Mindfulness help reduce opioid cravings, study finds

knowridge.com - 07/Feb 00:50

A new study has found that mindfulness-based group therapy helps people recovering from opioid addiction by significantly reducing their cravings. The...

Sorry! Image not available at this time

Rural clinics significantly boost buprenorphine prescribing with support program

news.medical.net - 28/Jan 02:36

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a...

Sorry! Image not available at this time

Attention-Deficit/Hyperactivity Disorder Tied to Shorter Life Expectancy

drugs.com - 27/Jan 16:01

MONDAY, Jan. 27, 2025 -- Adults with diagnosed attention-deficit/hyperactivity disorder (ADHD) have a shorter life expectancy than those without,...

Sorry! Image not available at this time

Chiropractic care linked to lower opioid disorder risks

knowridge.com - 31/Jan 10:48

A new study has found that adults with newly diagnosed sciatica who received chiropractic spinal manipulation (CSM) were significantly less likely to...

Sorry! Image not available at this time

Weed Use Tied To Increase in Schizophrenia

drugs.com - 05/Feb 11:02

WEDNESDAY, Feb. 5, 2025 -- Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of...

FDA Approves Esketamine Nasal Spray for Resistant Depression

medindia.net - 28/Jan 10:32

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive...

Sorry! Image not available at this time

FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

drugs.com - 30/Jan 02:01

BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration...

Anxiety reduction with antidepressants confirmed, long-term effects uncertain

news.medical.net - 30/Jan 11:59

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although...

Sorry! Image not available at this time

Multicomponent Prehabilitation Beneficial for Surgical Patients

drugs.com - 29/Jan 16:01

WEDNESDAY, Jan. 29, 2025 -- Exercise prehabilitation, nutritional prehabilitation, and multicomponent interventions involving exercise may be...

Sorry! Image not available at this time

CBD can help reduce alcohol use disorder symptoms

knowridge.com - 30/Jan 10:59

A new study has found that cannabidiol (CBD), a natural compound found in the cannabis plant, can reduce the craving for alcohol in people suffering...